Predicting radiation-induced valvular heart damage

References

• Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol 2013;61:2319–28.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi- modality imaging evaluation of cardiovascular complications of radiotherapy in adults: A report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013;14:721–40.
   PubMed Web of Science ®Google Scholar
• Ghobadi G, van der Veen S, Bartelds B, de Boer RA, Dickinson MG, de Jong JR, et al. Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys 2012;84:e639–46.
   PubMed Web of Science ®Google Scholar
• van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, Brandenburg S, et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 2007;69:552–9.
   PubMed Web of Science ®Google Scholar
• Andratschke N, Maurer J, Molls M, Trott KR. Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiother Oncol 2011;100:160–6.
   PubMed Web of Science ®Google Scholar
• Cella L, Palma G, Deasy JO, Oh JH, Liuzzi R, D’Avino V, et al. Complication probability models for radiation-induced heart valvular dysfunction: Do heart-lung interactions play a role? PloS One 2014;9:e111753.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, D’Avino V, Conson M, Di Biase A, Picardi M, et al. Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury. Acta Oncol 2013.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, D’Avino V, Salvatore M, Pacelli R. Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys 2013; 87:304–10.
   PubMed Web of Science ®Google Scholar
• Lee TF, Chao PJ, Ting HM, Chang L, Huang YJ, Wu JM, et al. Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of xerostomia after intensity-modulated radiotherapy for head and neck cancer. PloS One 2014;9:e89700.
   Google Scholar
• Xu CJ, van der Schaaf A, Schilstra C, Langendijk JA, van't Veld AA. Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2012; 82:e677–84.
   PubMed Web of Science ®Google Scholar
• Xu CJ, van der Schaaf A, Van't Veld AA, Langendijk JA, Schilstra C. Statistical validation of normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2012;84:e123–9.
   Google Scholar
• Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011;79:10–8.
   PubMed Web of Science ®Google Scholar
• Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442–57.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003; 30:979–85.
   PubMed Web of Science ®Google Scholar
• El Naqa I, Suneja G, Lindsay PE, Hope AJ, Alaly JR, Vicic M, et al. Dose response explorer: An integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Phys Med Biol 2006;51:5719–35.
   PubMed Web of Science ®Google Scholar
• Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: Challenge and opportunity. Semin Radiat Oncol 2003;13: 248–66.
   PubMed Web of Science ®Google Scholar
• Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases. Hum Pathol 1996;27:766–73.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, et al. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma. Radiother Oncol 2011;101:316–21.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003;42:743–9.
   PubMed Web of Science ®Google Scholar
• Wethal T, Lund MB, Edvardsen T, Fossa SD, Pripp AH, Holte H, et al. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. Br J Cancer 2009;101:575–81.
   PubMed Web of Science ®Google Scholar
• Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS. Radiation-associated cardiovascular disease: Manifestations and management. Semin Radiat Oncol 2003;13:346–56.
   PubMed Web of Science ®Google Scholar
• Briere T, Tucker S, Liao Z, Martel M. Small lung size increases the risk of radiation pneumonitis in lung cancer patients. Med Phys 2013;40:453.
   Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet 2006;368: 1005–11.
   PubMed Web of Science ®Google Scholar
• Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Statist Soc B 2005;67:301–7.
   Google Scholar
• Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
   PubMed Web of Science ®Google Scholar